SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-319532
Filing Date
2021-11-04
Accepted
2021-11-04 09:30:05
Documents
14
Period of Report
2021-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d254451d8k.htm   iXBRL 8-K 24291
2 EX-99.1 d254451dex991.htm EX-99.1 64676
6 GRAPHIC g254451g1104093920521.jpg GRAPHIC 4131
  Complete submission text file 0001193125-21-319532.txt   229188

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA igms-20211104.xsd EX-101.SCH 2873
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE igms-20211104_lab.xml EX-101.LAB 18122
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE igms-20211104_pre.xml EX-101.PRE 11392
7 EXTRACTED XBRL INSTANCE DOCUMENT d254451d8k_htm.xml XML 3357
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39045 | Film No.: 211378506
SIC: 2834 Pharmaceutical Preparations